AU600264B2 - Treatment of fungal infections - Google Patents

Treatment of fungal infections

Info

Publication number
AU600264B2
AU600264B2 AU71329/87A AU7132987A AU600264B2 AU 600264 B2 AU600264 B2 AU 600264B2 AU 71329/87 A AU71329/87 A AU 71329/87A AU 7132987 A AU7132987 A AU 7132987A AU 600264 B2 AU600264 B2 AU 600264B2
Authority
AU
Australia
Prior art keywords
treatment
fungal infections
fungal
infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU71329/87A
Other versions
AU7132987A (en
Inventor
Valerie Berry
Pamela Ann Hunter
Joshua Oduro-Yeboah
Norman Andrew Orr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868615669A external-priority patent/GB8615669D0/en
Priority claimed from GB868629641A external-priority patent/GB8629641D0/en
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of AU7132987A publication Critical patent/AU7132987A/en
Application granted granted Critical
Publication of AU600264B2 publication Critical patent/AU600264B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU71329/87A 1986-06-26 1987-04-09 Treatment of fungal infections Ceased AU600264B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB868615669A GB8615669D0 (en) 1986-06-26 1986-06-26 Treatment
GB8615669 1986-06-26
GB8629641 1986-12-11
GB868629641A GB8629641D0 (en) 1986-12-11 1986-12-11 Treatment

Publications (2)

Publication Number Publication Date
AU7132987A AU7132987A (en) 1988-01-07
AU600264B2 true AU600264B2 (en) 1990-08-09

Family

ID=26290960

Family Applications (1)

Application Number Title Priority Date Filing Date
AU71329/87A Ceased AU600264B2 (en) 1986-06-26 1987-04-09 Treatment of fungal infections

Country Status (8)

Country Link
US (1) US4790989A (en)
EP (1) EP0251434B1 (en)
AU (1) AU600264B2 (en)
DE (1) DE3780091T2 (en)
DK (1) DK186087A (en)
ES (1) ES2041681T3 (en)
GR (1) GR3005660T3 (en)
IE (1) IE59628B1 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8718886D0 (en) * 1987-08-10 1987-09-16 Ici America Inc Composition
US5279830A (en) * 1990-04-16 1994-01-18 Intellectual Property Holding Co. Mineral oil free and lanolin free cosmetic composition
US5026554A (en) * 1990-09-13 1991-06-25 Merck & Co., Inc. Method of inhibiting fungal growth using squalene synthetase inhibitors
GB9026873D0 (en) * 1990-12-11 1991-01-30 Beecham Group Plc Novel compounds
US5594026A (en) * 1990-12-11 1997-01-14 Smithkline Beecham Group P.L.C. Polymorphs of crystalline mupirocin
ES2157996T3 (en) * 1993-10-22 2001-09-01 Smithkline Beecham Corp NEW COMPOSITION
GB9507825D0 (en) * 1995-04-18 1995-05-31 Wet Pieter M De Method of treatment
GB9616208D0 (en) 1996-08-01 1996-09-11 Smithkline Beecham Plc Novel Compounds
CA2267248A1 (en) * 1996-10-01 1998-04-09 Smithkline Beecham P.L.C. Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms
CO4910145A1 (en) 1996-10-01 2000-04-24 Smithkline Beecham Corp USE
US6716435B1 (en) * 1997-04-18 2004-04-06 Ganeden Biotech, Inc. Absorbent product containing absorbent structure and Bacillus coagulans
US6645506B1 (en) * 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
CA2299298A1 (en) * 1997-08-09 1999-02-18 Jane Elizabeth Hilton Compositions for nasal administration
EP1033969A1 (en) * 1997-09-11 2000-09-13 Smithkline Beecham Plc Compositions adapted for prolonged residence in the nasal pharynx
IL123143A (en) * 1998-02-02 2001-08-26 Agis Ind 1983 Ltd Pharmaceutical compositions containing mupirocin
GB9808470D0 (en) 1998-04-22 1998-06-17 Smithkline Beecham Plc Novel process and apparatus
US6509177B1 (en) 1999-02-03 2003-01-21 Biogal Gyogyszergyar Rt. Process for the preparation of pseudomonic acid A antibiotic by microbiological method
IL137363A (en) * 2000-07-18 2005-12-18 Agis Ind 1983 Ltd Pharmaceutical compositions containing mupirocin
HUP0500797A2 (en) * 2001-06-21 2007-06-28 Biogal Gyogyszergyar Metabolic controlled fermentation process for pseudomonic acid production
US7737177B2 (en) * 2001-12-28 2010-06-15 TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság Processes for preparing crystalline and amorphous mupirocin calcium
WO2005009336A2 (en) * 2003-05-01 2005-02-03 Replidyne, Inc. Antibacterial methods and compositions
US20050123575A1 (en) * 2003-12-03 2005-06-09 Eilon Asculai Spreadable compositions for topical use, an improved process of making same and methods of using same
MXPA06010084A (en) * 2004-06-01 2007-03-01 Teva Gyogyszergyar Zartkoruen Process for preparation of amorphous form of a drug.
EP2444067A1 (en) 2010-10-20 2012-04-25 Laboratorios Ojer Pharma S.L. Anhydrous gel comprising mupirocin
WO2016133471A1 (en) 2015-02-20 2016-08-25 Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A. Ş. A topical composition comprising mupirocin and dexpanthenol
US9868669B2 (en) * 2015-09-25 2018-01-16 Mitsubishi Materials Corporation Precious metal clay regeneration solution and method for regenerating precious metal clay

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU555897B2 (en) * 1982-05-28 1986-10-16 Beecham Group Plc Topical pseudomonic acid formulations
AU577595B2 (en) * 1984-06-19 1988-09-29 Beecham Group Plc Crystalline calcium pseudomonate
AU582397B2 (en) * 1984-11-16 1989-03-23 Beecham Group Plc Mupirocin granules

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3837322A (en) * 1973-07-30 1974-09-24 Honda Motor Co Ltd Carburetor choke
GB8401965D0 (en) * 1984-01-25 1984-02-29 Beecham Group Plc Composition

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU555897B2 (en) * 1982-05-28 1986-10-16 Beecham Group Plc Topical pseudomonic acid formulations
AU577595B2 (en) * 1984-06-19 1988-09-29 Beecham Group Plc Crystalline calcium pseudomonate
AU582397B2 (en) * 1984-11-16 1989-03-23 Beecham Group Plc Mupirocin granules

Also Published As

Publication number Publication date
EP0251434A3 (en) 1988-02-24
DK186087D0 (en) 1987-04-10
US4790989A (en) 1988-12-13
ES2041681T3 (en) 1993-12-01
EP0251434A2 (en) 1988-01-07
IE59628B1 (en) 1994-03-09
DE3780091T2 (en) 1993-02-11
DE3780091D1 (en) 1992-08-06
IE870889L (en) 1987-12-26
EP0251434B1 (en) 1992-07-01
AU7132987A (en) 1988-01-07
GR3005660T3 (en) 1993-06-07
DK186087A (en) 1987-12-27

Similar Documents

Publication Publication Date Title
AU600264B2 (en) Treatment of fungal infections
AU6896487A (en) Hair treatment agent
AU7372091A (en) Treatment of sinus headache
AU1676588A (en) Treatment of materials
AU1359388A (en) Hair treatment composition
AU7044087A (en) Crop treatment processes
AU6979487A (en) Treatment of gases
AU3328693A (en) Treatment of fungal infections
AU3413389A (en) Method of treating retrovirus infection
AU591903B2 (en) Novel treatment
AU1279788A (en) Compounds and treatment
AU7884987A (en) Cathonic protection of surfaces
AU581672B2 (en) Novel treatment
AU591683B2 (en) Novel treatment
AU6660090A (en) Treatment of depression
AU7416887A (en) Treatment of chromate coating
AU8269787A (en) Flyslag treatment
AU7535681A (en) Treatment of infections
AU1477688A (en) External preparations of melanogenesis-inhibitory agent
ZA872553B (en) Treatment of fungal infections
AU7379587A (en) Pharmaceutical formulation for the treatment of bacterial infections
GB8611746D0 (en) Treating skin infections
AU551219B2 (en) 5-0-mycaminosyl tylonolide treatment of pasturella infections
AU6765887A (en) Treatment of water
AU7398587A (en) Treatment of soybeans